Suppr超能文献

使用负载免疫佐剂的多功能智能放射治疗生物材料引发远隔效应。

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants.

作者信息

Moreau Michele, Yasmin-Karim Sayeda, Kunjachan Sijumon, Sinha Neeharika, Gremse Felix, Kumar Rajiv, Chow Kwok Fan, Ngwa Wilfred

机构信息

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, MA, United States.

出版信息

Front Oncol. 2018 Mar 12;8:56. doi: 10.3389/fonc.2018.00056. eCollection 2018.

Abstract

In this study, we investigate the use of multifunctional smart radiotherapy biomaterials (SRBs) loaded with immunoadjuvants for boosting the abscopal effect of local radiotherapy (RT). SRBs were designed similar to currently used inert RT biomaterials, incorporating a biodegradable polymer with reservoir for loading payloads of the immunoadjuvant anti-CD40 monoclonal antibody. Lung (LLC1) tumors were generated both on the right and left flank of each mouse, with the left tumor representing metastasis. The mice were randomized and divided into eight cohorts with four cohorts receiving image-guided RT (IGRT) at 5 Gy and another similar four cohorts at 0 Gy. IGRT and Computed Tomography (CT) imaging were performed using a small animal radiation research platform (SARRP). Tumor volume measurements for both flank tumors and animal survival was assessed over 25 weeks. Tumor volume measurements showed significantly enhanced inhibition in growth for the right flank tumors of mice in the cohort treated with SRBs loaded with CD40 mAbs and IGRT. Results also suggest that the use of polymeric SRBs with CD40 mAbs without RT could generate an immune response, consistent with previous studies showing such response when using anti-CD40. Overall, 60% of mice treated with SRBs showed complete tumor regression during the observation period, compared to 10% for cohorts administered with anti-CD40 mAbs, but no SRB. Complete tumor regression was not observed in any other cohorts. The findings justify more studies varying RT doses and quantifying the immune-cell populations involved when using SRBs. Such SRBs could be developed to replace currently used RT biomaterials, allowing not only for geometric accuracy during RT, but also for extending RT to the treatment of metastatic lesions.

摘要

在本研究中,我们研究了负载免疫佐剂的多功能智能放射治疗生物材料(SRB)用于增强局部放射治疗(RT)的远隔效应。SRB的设计类似于目前使用的惰性RT生物材料,包含一种可生物降解的聚合物,并带有用于装载免疫佐剂抗CD40单克隆抗体的储存器。在每只小鼠的左右两侧都生成了肺(LLC1)肿瘤,左侧肿瘤代表转移瘤。将小鼠随机分为八个队列,其中四个队列接受5 Gy的图像引导放射治疗(IGRT),另外四个类似队列接受0 Gy的照射。使用小动物辐射研究平台(SARRP)进行IGRT和计算机断层扫描(CT)成像。在25周内评估双侧肿瘤的体积测量值和动物存活率。肿瘤体积测量结果显示,在接受负载CD40单克隆抗体的SRB和IGRT治疗的队列中,小鼠右侧肿瘤的生长受到显著增强的抑制。结果还表明,使用不含RT的含CD40单克隆抗体的聚合物SRB可产生免疫反应,这与之前使用抗CD40时显示的此类反应的研究一致。总体而言,在观察期内,接受SRB治疗的小鼠中有60%出现了肿瘤完全消退,而接受抗CD40单克隆抗体但未使用SRB的队列中这一比例为10%。在任何其他队列中均未观察到肿瘤完全消退。这些发现证明有必要开展更多研究,改变RT剂量并量化使用SRB时涉及的免疫细胞群体。此类SRB有望被开发出来替代目前使用的RT生物材料,不仅能在RT期间实现几何精度,还能将RT扩展至转移性病变的治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验